tm logo
VYCRINSA
Live/Pending
THIRD EXTENSION - GRANTED

granted

on 24 Jul 2024

Last Applicant/ Owned by

12780 El Camino Real

San Diego

CA

92130

Serial Number

97010798 filed on 03rd Sep 2021

Registration Number

N/A

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

VYCRINSA

pharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric, neurological, hormonal, genetic and endocrine disorders and conditions; pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions; pharmaceutic Read More

Classification Information


Class [005]
Pharmaceutical Products


pharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric, neurological, hormonal, genetic and endocrine disorders and conditions; pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97010798

Mark Type

No Service/Collective Mark

Attorney Docket Number

No NEUB 2110832

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
24th Jul 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24th Jul 2024SOU EXTENSION 3 GRANTED
24th Jul 2024SOU EXTENSION 3 FILED
24th Jul 2024SOU TEAS EXTENSION RECEIVED
25th Jan 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
23rd Jan 2024SOU EXTENSION 2 GRANTED
23rd Jan 2024SOU EXTENSION 2 FILED
23rd Jan 2024SOU TEAS EXTENSION RECEIVED
28th Jul 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
26th Jul 2023SOU EXTENSION 1 GRANTED